Orly Avni

Dr. Orly Avni


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Autoimmunity Reviews
Verified
Journal Article
Closed access
OSOded Shamriz
Oded Shamriz
HMHila Mizrahi
Hila Mizrahi
MWMichal Werbner
Michal Werbner
YSYehuda Shoenfeld
Yehuda Shoenfeld
OAOrly Avni
Orly Avni
OKOmry Koren
Omry Koren

11 December 2019 in EMBO Reports
Verified
Journal Article
Open access
PDF file
TMTal Meningher
Tal Meningher
YBYiftah Barsheshet
Yiftah Barsheshet
YOYifat Ofir‐Birin
Yifat Ofir‐Birin
DGDaniel Gold
Daniel Gold
BBBoris Brant
Boris Brant
Dror AvniDror Avni
Dror Avni
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

27 August 2019 in mSystems
Verified
Journal Article
Open access
PDF file
MWMichal Werbner
Michal Werbner
YBYiftah Barsheshet
Yiftah Barsheshet
NWNir Werbner
Nir Werbner
MZMor Zigdon
Mor Zigdon
IAItamar Averbuch
Itamar Averbuch
OAOrly Avni
Orly Avni
How do stressful life events increase the risk for autoimmune disorders? Here we show that chronic social stress in mice promotes the expression of virulent genes in the gut microbiota and alters the microbial translocation into the mesenteric lymph nodes. Our results also suggest that the consequent immune response to the stress-affected microbiota may endanger the tolerance for self. The presence of specific translocated bacteria and the immune response in the mesenteric lymph nodes can be diminished using an inhibitor of the bacterial communication system without drastically affecting the gut microbial composition as antibiotics do.

Verified
Journal Article
Open access
PDF file
HSHadas Samuels
Hadas Samuels
MMMalki Malov
Malki Malov
TSTrishna Saha
Trishna Saha
KZKarin Ben Zaken
Karin Ben Zaken
NBNaamah Bloch
Naamah Bloch
ASAbraham O. Samson
Abraham O. Samson
Autoimmune diseases (AIDs) are often co-associated, and about 25% of patients with one AID tend to develop other comorbid AIDs. Here, we employ the power of datamining to predict the comorbidity of AIDs based on their normalized co-citation in PubMed. First, we validate our technique in a test dataset using earlier-reported comorbidities of seven knowns AIDs. Notably, the prediction correlates well with comorbidity (R = 0.91) and validates our methodology. Then, we predict the association of 100 AIDs and classify them using principal component analysis. Our results are helpful in classifying AIDs into one of the following systems: (1) gastrointestinal, (2) neuronal, (3) eye, (4) cutaneous, (5) musculoskeletal, (6) kidneys and lungs, (7) cardiovascular, (8) hematopoietic, (9) endocrine, and (10) multiple. Our classification agrees with experimentally based taxonomy and ranks AID according to affected systems and gender. Some AIDs are unclassified and do not associate well with other AIDs. Interestingly, Alzheimer’s disease correlates well with other AIDs such as multiple sclerosis. Finally, our results generate a network classification of autoimmune diseases based on PubMed text mining and help map this medical universe. Our results are expected to assist healthcare workers in diagnosing comorbidity in patients with an autoimmune disease, and to help researchers in identifying common genetic, environmental, and autoimmune mechanisms.

9 January 2017 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
TFTzipora C Falik-Zaccai
Tzipora C Falik-Zaccai
YBYiftah Barsheshet
Yiftah Barsheshet
HMHanna Mandel
Hanna Mandel
MSMeital Segev
Meital Segev
ALAvraham Lorber
Avraham Lorber
OAOrly Avni
Orly Avni
Dilated cardiomyopathy (DCM) is a life‐threatening disorder whose genetic basis is heterogeneous and mostly unknown. Five Arab Christian infants, aged 4–30 months from four families, were diagnosed with DCM associated with mild skin, teeth, and hair abnormalities. All passed away before age 3. A homozygous sequence variation creating a premature stop codon at PPP1R13L encoding the iASPP protein was identified in three infants and in the mother of the other two. Patients’ fibroblasts and PPP1R13L‐knocked down human fibroblasts presented higher expression levels of pro‐inflammatory cytokine genes in response to lipopolysaccharide, as well as Ppp1r13l‐knocked down murine cardiomyocytes and hearts of Ppp1r13l‐deficient mice. The hypersensitivity to lipopolysaccharide was NF‐κB‐dependent, and its inducible binding activity to promoters of pro‐inflammatory cytokine genes was elevated in patients’ fibroblasts. RNA sequencing of Ppp1r13l‐knocked down murine cardiomyocytes and of hearts derived from different stages of DCM development in Ppp1r13l‐deficient mice revealed the crucial role of iASPP in dampening cardiac inflammatory response. Our results determined PPP1R13L as the gene underlying a novel autosomal‐recessive cardio‐cutaneous syndrome in humans and strongly suggest that the fatal DCM during infancy is a consequence of failure to regulate transcriptional pathways necessary for tuning cardiac threshold response to common inflammatory stressors. Synopsis A new cardio‐cutaneous syndrome associated with fatal dilated cardiomyopathy is discovered in children with sequence variations in PPP1R13L, which encodes for iASPP. Patient skin‐derived fibroblasts are hypersensitive to inflammatory stimuli, responding with NF‐κB‐dependent high expression levels of pro‐inflammatory cytokines. In a murine model, the affected hearts are associated with pro‐inflammatory transcriptional programs starting early after birth. Further abnormal increase happens with age and in response to inflammatory triggers. Sublethal doses of LPS are fatal in the murine model.

1 May 2018 in Cell Host & Microbe
Verified
Journal Article
Closed access
OAOrly Avni
Orly Avni
OKOmry Koren
Omry Koren